News

Media And Political Bulletin – 04 March 2020

Media and Political Bulletin

04 March 2020

Media Summary

Coronavirus: Drug shortage fears as India limits exports

BBC News, 04 March 2020

BBC News reports that there are fears of global shortages of some common drugs after India, the world’s biggest supplier of generic drugs, has restricted exports of 26 ingredients and the medicines made from them due to the coronavirus. The restricted drugs include Paracetamol, one of the world’s most widely-used pain relievers.

It comes as many drug ingredient makers in China remain shut or cut output. India’s drug makers rely on China for almost 70% of the active ingredients in their medicines, and industry experts have warned that they are likely to face shortages if the epidemic continues.

Oxford Economic’s lead economist Stephen Foreman told the BBC that there are indications that the scarcity of ingredients is already forcing up prices.

This was reported in a number of publications, including ReutersBloombergPMLiVE and European Pharmaceutical Review.

New figures show 3.5 million unlicensed erection pills seized in 2019

MHRA, 03 March 2020

According to new figures released by the MHRA, around 3.5 million unlicensed erection pills worth more than £10 million were seized in the UK in 2019.

The MHRA is warning people not to take a chance with fake medicines as it launches the next phase of its #FakeMeds campaign, this time focusing on fake erectile dysfunction (ED) medicines sold online.

More than half of all medicines and medical devices bought online are fake or counterfeit, highlighting the need for enforcement activity and public awareness to protect and improve the UK’s public health.

Mark Jackson, MHRA Head of Enforcement, said: “Any medication bought from an unregistered website may be fake and will not meet quality and safety standards. We encourage people not to take a chance with fake medicines – make sure you are buying from a legitimate source.”

 

 

Parliamentary Coverage

Commons Tabled Written Question – DH and Social Care

03 March 2020

Ms Harriet Harman (Camberwell and Peckham): To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that women in Camberwell and Peckham constituency have adequate access to Hormone Replacement Therapy (HRT); and if he makes an assessment of the adequacy of the medicine supply chain in relation to HRT.

Commons Second Reading – Medicines and Medical Devices Bill

02 March 2020

The Medicines and Medical Devices Bill has had its Second Reading in the House of Commons.

The Bill aimed to create a strong and nimble regulatory framework post-Brexit, with patient safety at its heart. The Bill would also increase the range of healthcare professionals who could prescribe medicines. The Opposition “broadly” supported the Bill and it passed without division.

 

Full Coverage

Coronavirus: Drug shortage fears as India limits exports

BBC News, 04 March 2020

There are fears of global shortages of some common drugs after India limited the export of certain medicines due to the coronavirus.

The world’s biggest supplier of generic drugs has restricted exports of 26 ingredients and the medicines made from them.

The restricted drugs include Paracetamol, one of the world’s most widely-used pain relievers.

It comes as many drug ingredient makers in China remain shut or cut output.

India’s drug makers rely on China for almost 70% of the active ingredients in their medicines, and industry experts have warned that they are likely to face shortages if the epidemic continues.

“Even drugs that aren’t produced in China get their base ingredients from China. Globally there could be a shortage if China and India both get hit,” warned analyst Shaun Rein from the China Market Research Group.

The list of ingredients and medicines accounts for 10% of all Indian pharmaceutical exports and includes several antibiotics, such as tinidazole and erythromycin, the hormone progesterone and Vitamin B12.

Oxford Economic’s lead economist Stephen Foreman told the BBC that there are indications that the scarcity of ingredients is already forcing up prices: “There are already signs that the reduction in supply to India has pushed up prices there considerably.”

The Indian government has urged calm over its announcement and said there were enough stocks to last for up to three months.

In 2018 Indian imports accounted for almost a quarter of US medicines and more than 30% of medicine ingredients, according to the US Food and Drug Administration (FDA).

FDA Commissioner Stephen Hahn told US senators on Tuesday that the agency is working to determine how the restrictions will affect America’s medical supply and its effect on essential medicines.

Major US pharmaceutical companies have said they are monitoring their supply chains.

Mylan warned last week that there could be drug shortages, while Eli Lilly said it does not expect the coronavirus outbreak to result in shortages for any of its therapies, including insulin products.

This was reported in a number of publications, including ReutersBloombergPMLiVE and European Pharmaceutical Review.

New figures show 3.5 million unlicensed erection pills seized in 2019

MHRA, 03 March 2020

Around 3.5 million unlicensed erection pills worth more than £10 million were seized in the UK in 2019 according to new figures released today by the Medicines and Healthcare products Regulatory Agency (MHRA).

The MHRA is warning people not to take a chance with fake medicines as it launches the next phase of its #FakeMeds campaign, this time focusing on fake erectile dysfunction (ED) medicines sold online.

Erectile problems in general affect up to 21% of men in the UK, which is equivalent to 4.3 million men in the UK. Despite this, it has been found that 44% of men with ED aged 40 and over have not sought medical help and may be buying fake products online.

Fake ED drugs can lead to more than just a let-down in the bedroom. There is no way of knowing what is in them nor the negative health effects they can have. Whilst it might seem appealing to skip the need for an assessment from a healthcare professional by buying medicines online, men with erectile problems may be putting their health at risk. Fake medicines may not contain any active ingredients, or worse, may contain toxic ingredients which could lead to serious health consequences.

The MHRA’s enforcement team has worked with UK Border Force to seize millions of unlicensed medicines at the border. Often illegal traders pose as legitimate suppliers, selling medications that are unlicensed for the UK market and offering tempting prices lower than the real deal. Since the launch of the #FakeMeds campaign in 2016, the MHRA has been continuing to crack down by closing illegally operating sites selling unlicensed products.

More than half of all medicines and medical devices bought online are fake or counterfeit, highlighting the need for enforcement activity and public awareness to protect and improve the UK’s public health.

With this new phase of #FakeMeds the agency is using the campaign to encourage people who buy medication online to make sure they are purchasing from safe and legitimate sources. It also encourages people to report suspected dodgy ED drugs, and any side effects experienced to the Yellow Card scheme.

Mark Jackson, MHRA Head of Enforcement, said:

Fake ED drugs might not give you the result you want or even make you ill. Any medication bought from an unregistered website may be fake and will not meet quality and safety standards. We encourage people not to take a chance with fake medicines – make sure you are buying from a legitimate source.

Visit the #FakeMeds website for tools and resources to help people purchase medication or medical devices safely online. If you have any questions about ED, please speak to a healthcare professional.

Ends

Notes to editor

  1. The #FakeMeds campaign is a public health campaign which aims to reduce the harm caused by purchasing fake, unlicensed or counterfeit medical products online. Phase 3 of the #FakeMeds campaign will focus on the issue of fake erectile dysfunction (ED) medicines and raise awareness of the prevalence of fake ED medicines online and encouraging audiences to buy from legitimate sources. Previous phases of the campaign have focused on dodgy diet pills and fake self-testing STI kits. Follow #FakeMeds on Twitter, Facebook and Instagram.
  2. The Medicines and Healthcare products Regulatory Agency is responsible for regulating all medicines and medical devices in the UK by ensuring they work and are acceptably safe. All our work is underpinned by robust and fact-based judgements to ensure that the benefits justify any risks.
  3. The MHRA is a centre of the Medicines and Healthcare products Regulatory Agency which also includes the National Institute for Biological Standards and Control (NIBSC)and the Clinical Practice Research Datalink (CPRD). The MHRA is an executive agency of the Department of Health and Social Care.
  4. The Yellow Card scheme helps the MHRA monitor the safety of all healthcare products in the UK to ensure they are acceptably safe for patients and those that use them.
  5. Erectile problems in general affect up to 21% of men in the UK according to Kantar TNS Omnibus Survey Dec 2010 – in a survey of 1,033 men.
  6. 44% of men with erectile dysfunction (ED) aged 40 and over have not sought medical help according to Opinium for Pfizer: ED market research, February 2018.
Media And Political Bulletin – 04 March 2020

From Factory to Pharmacy

As part of our mission to build awareness, understanding and appreciation of the vital importance of the healthcare distribution sector, we developed an infographic explaining the availability of medicines. It identifies the factors that can impact drug supply, as well as the measures that HDA members undertake day in, day out to help mitigate the risks of patients not receiving their medicines.

See the Infographic

Apply to become a Member

Membership of the HDA guarantees your organisation:

  • Access to leading policy and industry forums of debate and discussion
  • Invitations to a range of networking industry events organised through the year, including an Annual Conference and a Business Day
  • Representation on HDA working parties, including the Members’ Liaison Group
  • A daily Political and Media Bulletin and HDA Newsletters
  • Access to HDA policy documents and all sections of the HDA website
  • Branding and marketing opportunities
Apply Now

Already a Member?